−0.0074USD
−16.43 MUSD
304.96 MUSD
1.32 B
About Viva Biotech Holdings
Sector
Industry
CEO
Chen Mao
Website
Headquarters
Shanghai
Employees (FY)
2.08 K
Founded
2008
ISIN
KYG9390W1015
FIGI
BBG00Q8HRQN4
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.
Viva Biotech (1873.HK) Good Sign to buy!?Share price of Viva Biotech (1873.HK) was up by 19.6% to $10.44 today (5th Aug 2020).
The share price has been passed over the last highest price ($10.16) one month ago on 7th Jul 2020.
Pivot point was existed and come together with a high volume and was ended up to the highest price.
Therefore, it
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VBIZF is 0.0500 USD — it has decreased by 53.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Viva Biotech Holdings stocks are traded under the ticker VBIZF.
Viva Biotech Holdings is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
VBIZF stock is 117.00% volatile and has beta coefficient of 1.55. Check out the list of the most volatile stocks — is Viva Biotech Holdings there?
Yes, you can track Viva Biotech Holdings financials in yearly and quarterly reports right on TradingView.
VBIZF net income for the last quarter is −16.20 M USD, while the quarter before that showed 146.15 K USD of net income which accounts for −11.18 K% change. Track more Viva Biotech Holdings financial stats to get the full picture.
Today Viva Biotech Holdings has the market capitalization of 118.88 M, it has decreased by 8.38% over the last week.
Like other stocks, VBIZF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Viva Biotech Holdings stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 2.08 K employees. See our rating of the largest employees — is Viva Biotech Holdings on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Viva Biotech Holdings technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Viva Biotech Holdings stock shows the sell signal. See more of Viva Biotech Holdings technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Viva Biotech Holdings EBITDA is 56.73 M USD, and current EBITDA margin is 18.53%. See more stats in Viva Biotech Holdings financial statements.